Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0793
    -0.0036 (-0.33%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2624
    -0.0014 (-0.11%)
     
  • USD/JPY

    151.4050
    +0.1590 (+0.11%)
     
  • Bitcoin USD

    70,849.98
    +1,497.62 (+2.16%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Blog Exposure - Bruker Buys Dutch Milk Analysis Equipment Manufacturer Lactotronic to Expand its Presence in the Dairy Industry

Stock Monitor: Enzo Biochem Post Earnings Reporting

LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want access to our free research report on Bruker Corp. (NASDAQ: BRKR), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=BRKR as the Company's latest news hit the wire. On July 03, 2018, the Company announced that it has signed an agreement to acquire the entire business of Drachten, The Netherlands-based Lactotronic B.V. Lactotronic specializes in developing, manufacturing, and distributing milk analyzing equipment and instruments for the dairy industry. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Enzo Biochem, Inc. (NYSE: ENZ), which also belongs to the Healthcare sector as the Company Bruker. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=ENZ
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Bruker most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=BRKR

The financial terms and other details of the acquisition were not shared by any of the two Companies.

Quotes from Management

Sharing his views on the acquisition of Lactotronic, Urban Faeh, President - Optics division of Bruker, said:

"As we expand in the food analysis markets, the acquisition of Lactotronic accelerates our development of solutions for milk and dairy analysis and expands our dairy market presence. The Lactotronic technologies expand our food analysis offerings, and we welcome the talented Lactotronic team with their valuable expertise and long experience in milk analysis."

Sietze Sietzema, Founder of Lactotronic, added:

"The Lactotronic team is proud to become part of Bruker. We believe that Bruker provides the environment for ongoing developments in dairy analysis solutions, and we are pleased to further broaden the food analysis capabilities of Bruker."

About the Acquiree - Lactotronic B.V.

Lactotronic is a developer and manufacturer of analytical instruments for the dairy industry. The Company has over 25 years of expertise in the area of milk analysis and its product offerings include high quality and high precision analytical equipment for milk laboratories, including the MIRA™ milk analyzer, which are used for standardization of routine milk analysis processes. The Company mainly provides laboratory equipment that are used for analysis of milk and milk products, and the equipment help in determining the main constitutes of dairy products. The equipment also allows milk laboratories with better milk quality control and verification of end products for increase in production efficiency.

The current transaction builds on the existing relationship between Bruker and Lactotronic. Both Companies have been jointly developing a high-end FT-NIR dairy analyzer. This analyzer has the ability to analyze different samples of liquid milk products, and solid and semi-solid dairy products. Bruker expects that the deal will enable it to expand its technology and product portfolio in the area of food analysis in the dairy industry.

About the Acquirer - Bruker Corp.

Bruker was founded in Karlsruhe, Germany in 1961 by Günther Laukien. With its headquarters in Billerica, Massachusetts, Bruker is a global manufacturer of high-end analytical instruments which are used by academic & government, pharma/biotech, clinical diagnostic, and industrial markets. The Company's portfolio of scientific instrumentation products includes magnetic technologies, spectroscopy and spectrometers, atomic force microscopy, diagnostic products, and X-ray technologies. The Company's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. The Company has a global presence across 90 locations on all continents and is supported by a team of over 6,000 employees.

Stock Performance Snapshot

July 05, 2018 - At Thursday's closing bell, Bruker's stock marginally climbed 0.76%, ending the trading session at $29.21.

Volume traded for the day: 360.64 thousand shares.

After yesterday's close, Bruker's market cap was at $4.62 billion.

Price to Earnings (P/E) ratio was at 30.05.

The stock has a dividend yield of 0.55%.

The stock is part of the Healthcare sector, categorized under the Medical Laboratories & Research industry. This sector was up 1.0% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

SOURCE: Active-Investors

Advertisement